CAESAR RANGEL: Open Payments
NPI 1093420804 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 4 payments from 3 companies in 2025. Trend: 2023 $1,494 · 2024 $967 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $248 |
| Teva Pharmaceuticals USA, Inc. | 1 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $117 |
Products named: COBENFY, UZEDY, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
